Sign in

Fatty liver disease (MASLD/MASH) trials, also abroad

426 open Fatty liver disease (MASLD/MASH) trials worldwide. Travel and costs are your own unless the study pays them; ask the study team first.

CountryOpen trials
United States100
China73
France32
Italy32
Spain30
United Kingdom24
Germany23
Egypt21
Canada18
India18
Taiwan18
Belgium17
Netherlands15
Hong Kong14
South Korea14
Poland13
Switzerland12
Mexico11
Türkiye11
Australia10
Puerto Rico10
Austria9
Denmark9
Japan9
Argentina8
Bulgaria8
Czechia8
Singapore8
Finland7
Greece7
Brazil6
New Zealand6
Sweden6
Chile5
Hungary5
Israel5
Romania5
Saudi Arabia5
Georgia4
Pakistan4
Kazakhstan3
Malaysia3
Portugal3
Thailand3
South Africa3
Jordan2
Kuwait2
Cyprus1
French Guiana1
Guadeloupe1
Croatia1
Indonesia1
Ireland1
Iran1
Réunion1
Russia1
Ukraine1
Vietnam1

The same trial often runs in several countries

A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) has 2 sites in Norway and runs in 34 countries. If a site near you is full, another one may still take people.

See A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) in all 34 countries